Clinical Trials in San Diego

Showing 10921-10940 of 12,589 trials

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

NCT00971048

To compare HP828-101 to standard of care for the management of partial or full thickness wounds

Healthpoint88 participantsStarted Sep 2009

Bakersfield, California, United States • Chula Vista, California, United States • Fresno, California, United States +8 more locations

COMPLETEDPhase 2< 1 mile

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

NCT01124565

This study's objective is to evaluate if RT001 is safe and well-tolerated following two (2) sequential applications.

Lateral Canthal LinesCrow's FeetFacial Wrinkles

Revance Therapeutics, Inc.40 participantsStarted May 2010

Birmingham, Alabama, United States • San Diego, California, United States • Omaha, Nebraska, United States

COMPLETEDPhase 2< 1 mile

Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

NCT00862459

The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Gadavist when used for taking images of the brain and spine. The results of the MRI with Gadavist Injection will be compared to the results of MR images taken without contrast and with the results of the MR images taken with OptiMARK.

Brain DiseasesSpinal Cord Diseases

Bayer237 participantsStarted Aug 2005

Sacramento, California, United States • San Diego, California, United States • Jacksonville, Florida, United States +24 more locations

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Find Trials by Condition in San Diego

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for 3D Measurements of the Eye

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Phase 2 Chronic Low Back Pain Study

Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma

Clinical Evaluation of the Crosstrees Pod™ in the Treatment of Pathologic Fracture of the Vertebral Body (Levels T4 - L5) in Adult Patients

Study to Evaluate the Prospective Payment System

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

Autologous Vaccine for Follicular Lymphoma

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes